Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Aleli M. Ayala-Marin"'
Autor:
Angela Pattatucci, Maria E. Fernandez, Camille Velez-Alamo, Natalie Fernández-Espada, Vivian Colón-López, Aleli M. Ayala-Marin
Publikováno v:
Health Educ Behav
Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer-related death among women in Puerto Rico (PR). The purpose of this study was to identify factors associated with never screened status among a sample of women nonadhe
Autor:
Aleli M. Ayala-Marin, Vivian Colón-López, Natalie Fernández-Espada, Maria E. Fernandez, Camille Vélez
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 23:B70-B70
Background: In Puerto Rico (PR), breast cancer was reported to be the leading cancer among women, accounting for approximately 31% of new cancer cases and 52% of cancer deaths. Mammography screening can reduce mortality approximately 20% by detecting
Autor:
Aleli M. Ayala-Marin, Nadia Lazo, Katherine J. Briant, Martha Gonzalez, Rosa Ortiz, Evelyn Gonzalez, Yonaira M. Rivera, Rose A. Treviño Whitaker, Sandra San Miguel, Janet Sanchez, Natalia I. Heredia, Lizette Rangel, Mayra Serrano, Niyati Desai, Diego Gómez-Aristizabal, Leticia A. Gatus
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 25:A31-A31
Purpose: The National Cancer Institute's (NCI) Center to Reduce Cancer Health Disparities (CRCHD) has been working to strengthen community outreach capacity through Community Health Educators (CHEs) of the NCI National Outreach Network (NON). The NON
Autor:
Hernan Rosado-Carpena, Alelí M. Ayala-Marín, Maria E. Fernandez, Camille Velez-Alamo, Shelciy Collazo-Castro, Dianedis Toro, Omayra Salgado-Cruz, Vivian Colón-López, Guillermo Tortolero-Luna, Marta Sanchez-Aracil, Marievelisse Soto-Salgado, Willmar Contreras, Voces Puerto Rico Vaccination Coalition, Maria Figueroa-Gonzalez
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 25:A36-A36
Background: Human Papillomavirus (HPV) is a common sexually transmitted infection among college students, a group still eligible for HPV vaccination. The President's Cancer Panel has identified missed opportunities in the promotion for catch-up vacci